Long‐term Longitudinal Observation of Lenvatinib‐associated Adverse Events in Patients With Unresectable Radioiodine‐refractory Differentiated Thyroid Cancer
This longitudinal study revealed which AEs appeared and when. The findings provide useful information about when and which AEs we should be attentive to during daily practice.
Authors
- Akiko Iguchi‐Manaka (ORCID: https://orcid.org/0000-0002-0338-130X)
- Yuka Aida (ORCID: https://orcid.org/0009-0000-6269-0586)
- Ikuo Sekine (ORCID: https://orcid.org/0000-0003-1105-7339)
- Emika Ichioka
- Joichi Usui (ORCID: https://orcid.org/0000-0002-6709-4000)
- Sachie Hashimoto (ORCID: https://orcid.org/0000-0001-5973-9051)
- Masato Homma (ORCID: https://orcid.org/0000-0002-4824-3242)
- Toshio Suzuki (ORCID: https://orcid.org/0000-0003-3477-3418)
- Hisato Hara (ORCID: https://orcid.org/0000-0002-2764-0353)
- Yusuke Watanabe
Institutions
- University of Tsukuba (JP)
- University of Tsukuba Hospital (JP)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1111/ajco.14211
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00